AGREEMENTEmployment Agreement • September 1st, 2006 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledSeptember 1st, 2006 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is made and entered into this 25th day of August, 2006, effective the 1st day of September, 2006 (the “Effective Date”) by and between CATALYST PHARMACEUTICAL PARTNERS, INC., a Delaware corporation, with offices located in Coral Gables, Florida (the “Company”) and CHARLES W. GORODETZKY, M.D., Ph.D., an individual resident of the state of Missouri (“Gorodetzky”).
AGREEMENT AND PLAN OF MERGERMerger Agreement • September 1st, 2006 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 1st, 2006 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of August 14, 2006, is made and entered into by and between Catalyst Pharmaceutical Partners, Inc., a Florida corporation (“Parent”) and Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (“Subsidiary”).
CONSULTING AGREEMENTConsulting Agreement • September 1st, 2006 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledSeptember 1st, 2006 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (this “Agreement”) is entered into this 28th day of October, 2004, effective October 1, 2004 (“Effective Date”), by and between CATALYST PHARMACEUTICAL PARTNERS, INC., a Florida corporation with offices located in Coral Gables, Florida (the “Company”), and JACK WEINSTEIN, an individual resident of the State of New Jersey (the “Consultant”).
CONSULTING AGREEMENTConsulting Agreement • September 1st, 2006 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledSeptember 1st, 2006 Company Industry JurisdictionCatalyst Pharmaceutical Partners, Inc. (hereinafter “COMPANY”) and Dr. Donald Jasinski (hereinafter “CONSULTANT”) 3 Barranco Court, Towson, MD 21204 agree that CONSULTANT will advise COMPANY on matters relating to the field of clinical studies with vigabatrin to treat cocaine/methamphetamine addiction (hereinafter “Field”) under the following terms and conditions (“this Agreement”):
CONSULTING AGREEMENTConsulting Agreement • September 1st, 2006 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledSeptember 1st, 2006 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (this “Agreement”) is entered into this 3rd day of January, 2005 (“Effective Date”) by and between CATALYST PHARMACEUTICAL PARTNERS, INC., a Florida corporation with offices located in Coral Gables, Florida (the “Company”), and CHARLES O’KEEFFE, an individual resident of the State of Virginia (the “Consultant”).